Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients

Sarah Burkill, Celeste M. Porsbjerg, Arnaud Bourdin, Trung N Tran, Neil Martin, Rohit Katial, Peter Barker, Michael E Wechsler, Jorge F Maspero, Sinthia Bosnic-Anticevich, Li Ping Chung, Gregory Katsoulotos, George Christoff, Todor A Popov, Mohsen Sadatsafavi, Carlos A. Torres-Duque, Charlotte Ulrik, Karin Dahl Assing, Susanne Hansen, Alan AltrajaLauri A. Lehtimäki, Nikolaos G Papadopoulos, Konstantinos Kostikas, Sundeep Salvi, Richard W Costello, Francesca Puggioni, Takashi Iwanaga, Chin Kook Rhee, Mona Al-Ahmad, Désirée Larenas-Linnemann, João A. Fonseca, Rita Amaral, Riyad Al-Lehebi, Luis Perez de Llano, Bruce Kirenga, Ming-Ju Tsai, Bassam Mahboub, Paul E Pfeffer, William Henley, Yang Liu, Juntao Lyu, Celine Goh, Thendral Uthaman, David Price, ISAR IGNITE

Research output: Contribution to journalAbstractpeer-review

Original languageEnglish
Article number3305
Number of pages1
JournalEuropean Respiratory Journal
Volume60
Issue number66
Early online date30 Nov 2022
DOIs
Publication statusPublished - 1 Dec 2022
EventEuropean Respiratory Society (ERS) International Congress. - FIRA Barcelona Gran Via Congress Centre, Barcelona, Spain
Duration: 4 Sept 20226 Sept 2022
https://www.ersnet.org/congress-and-events/congress/

Bibliographical note

Funding: This study was conducted by the Observational and Pragmatic Research Institute (OPRI) Pte Ltd and was partially funded by Optimum Patient Care Global and AstraZeneca Ltd. No funding was received by OPRI for its contribution.

Cite this